NASDAQ:NRXS NeurAxis (NRXS) Stock Price, News & Analysis $3.20 -0.79 (-19.80%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$3.06 -0.15 (-4.53%) As of 09:24 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock About NeurAxis Stock (NASDAQ:NRXS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get NeurAxis alerts:Sign Up Key Stats Today's Range$3.00▼$3.4450-Day Range$1.62▼$3.9952-Week Range$1.33▼$6.20Volume3.15 million shsAverage Volume396,524 shsMarket Capitalization$23.09 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewNeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.Read More… Receive NRXS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NeurAxis and its competitors with MarketBeat's FREE daily newsletter. Email Address NRXS Stock News HeadlinesNeurAxis, Inc. (NASDAQ:NRXS) Major Shareholder Brian Hannasch Acquires 18,065 SharesApril 24, 2025 | insidertrades.comNeurAxis, Inc. Announces $5 Million Stock OfferingMay 22 at 7:18 AM | tipranks.comHere’s your answerPorter Stansberry is stepping into the spotlight — and putting real skin in the game. For the first time ever, he’s opening the doors to a live, real-money trading account, managed transparently with the same strategies he’s used to build long-term wealth. Every 90 days, he and his lead analyst release a new tranche of trades designed for serious investors who don’t want to babysit the market. The goal: income, downside protection, and asymmetric upside.May 22, 2025 | Porter & Company (Ad)Best Penny Stocks To Research - May 20thMay 22 at 4:55 AM | americanbankingnews.comNeurAxis, Inc. Receives $1 Million from Warrant ExercisesMay 21 at 5:55 PM | tipranks.comNeurAxis Announces $5.0 Million Registered Direct OfferingMay 21 at 4:21 PM | finance.yahoo.comNeurAxis Announces $5.0 Million Registered Direct OfferingMay 21 at 7:00 AM | globenewswire.comNeuraxis Stock Price, Quotes and Forecasts | AMEX:NRXS | BenzingaMay 21 at 6:37 AM | benzinga.comSee More Headlines NRXS Stock Analysis - Frequently Asked Questions How have NRXS shares performed this year? NeurAxis' stock was trading at $2.35 at the beginning of the year. Since then, NRXS stock has increased by 36.2% and is now trading at $3.20. View the best growth stocks for 2025 here. How were NeurAxis' earnings last quarter? NeurAxis, Inc. (NASDAQ:NRXS) announced its earnings results on Tuesday, November, 12th. The company reported ($0.25) earnings per share for the quarter. The company earned $0.67 million during the quarter. When did NeurAxis IPO? NeurAxis (NRXS) raised $7 million in an initial public offering on Wednesday, August 9th 2023. The company issued 1,098,667 shares at $6.00 per share. Who are NeurAxis' major shareholders? Top institutional shareholders of NeurAxis include AIGH Capital Management LLC (0.28%). View institutional ownership trends. How do I buy shares of NeurAxis? Shares of NRXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of NeurAxis own? Based on aggregate information from My MarketBeat watchlists, some other companies that NeurAxis investors own include AutoZone (AZO), Intel (INTC), Meta Platforms (META), AMMO (POWW), SPDR S&P 500 ETF Trust (SPY), TJX Companies (TJX) and ETRACS Crude Oil Shares Covered Call ETN (USOI). Company Calendar Last Earnings11/12/2024Today5/22/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryMedical Equipment Current SymbolNASDAQ:NRXS CIK1933567 Webneuraxis.com Phone(812) 689-0791FaxN/AEmployees19Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.19) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-14,630,000.00 Net Margins-492.76% Pretax Margin-341.35% Return on EquityN/A Return on Assets-641.25% Debt Debt-to-Equity RatioN/A Current Ratio0.24 Quick Ratio0.23 Sales & Book Value Annual Sales$2.69 million Price / Sales8.60 Cash FlowN/A Price / Cash FlowN/A Book Value($0.27) per share Price / Book-11.85Miscellaneous Outstanding Shares7,216,000Free Float6,085,000Market Cap$23.09 million OptionableNot Optionable Beta3.34 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free Report This page (NASDAQ:NRXS) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump + Musk = AI’s turning pointTrump may not code… but he knows how to pick winners. And according to insiders, his administration is prep...True Market Insiders | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeurAxis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeurAxis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.